Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 June 2008

Tob Control. Published Online First: 19 February 2008. doi:10.1136/tc.2007.022368
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
tc.2007.022368v1
17/3/177    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Thavorn, K.
Right arrow Articles by Chaiyakunapruk, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thavorn, K.
Right arrow Articles by Chaiyakunapruk, N.

RESEARCH PAPERS

A cost-effectiveness analysis of a community pharmacist-based smoking cessation program in Thailand

Kednapa Thavorn1, Nathorn Chaiyakunapruk2,3

1 School of Pharmacy, Naresuan University, Thailand;
2 School of Pharmacy, Naresuan University PLUS 2 MORE AFFILIATIONS. See the manuscript, Thailand

To whom correspondence should be addressed. gthavorn{at}yahoo.com

To whom correspondence should be addressed. nui{at}u.washington.edu


ABSTRACT
Objective: To estimate the incremental cost-effectiveness ratio of a structured community pharmacist-based smoking cessation program compared with usual care.

Design: A cost-effectiveness study using a health care system perspective.

Population: Two simulated cohorts of smokers: male and female aged 40, 50, and 60 years who regularly smoke 10-20 cigarettes per day.

Intervention and comparator: A structured community pharmacist-based smoking cessation (CPSC) program compared to usual care.

Main outcome measure: Cost per life year gained (LYG) attributable to the smoking cessation program.Results: The community pharmacist-based smoking cessation program results in cost-savings of 17,503.53 baht (US$500) to the health system and life year gains of 0.181 years for men and; costs-savings of 21,499.75 baht (US$614) and life year gains of 0.244 years for women. A series of sensitivity analyses demonstrate that both cost-savings and life year gains were sensitive to variations in the discount rate and the long term smoking quit rate associated with the intervention.

Conclusion: From the perspective of the health system, the community pharmacist-based smoking cessation program yields cost-savings and life year gains. This finding provides important information for health policy decision makers when determining the magnitude of resources to be allocated to smoking cessation service in community pharmacy.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.